QRISK validation and evaluation Authors' reply

QRISK validation and evaluation Authors' reply

書目詳細資料
Main Authors:	Collins, G, Altman, D
格式:	Journal article
語言:	English
出版:	2009

相似書籍

UPDATED VERSION OF QRISK2 Authors' reply to Bird
由: Collins, G, et al.
出版: (2012)

QRISK validation and evaluation. QRISK may be less useful.
由: Liew, S, et al.
出版: (2009)

QRISK validation and evaluation: QRISK may be less useful
由: Su, M, et al.
出版: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
由: Collins, G, et al.
出版: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
由: Collins, G, et al.
出版: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
由: Collins, G, et al.
出版: (2009)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
由: Collins, G, et al.
出版: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
由: Collins, G, et al.
出版: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
由: Collins, G, et al.
出版: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
由: Collins, G, et al.
出版: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
由: Collins, G, et al.
出版: (2012)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
由: Collins, G, et al.
出版: (2012)

Authors' reply to Bird.
由: Collins, G, et al.
出版: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
由: Manpreet Singh, et al.
出版: (2022-07-01)

The authors reply
由: Collins, R, et al.
出版: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
由: Parsons, RE, et al.
出版: (2023)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
由: Hippisley-Cox, J, et al.
出版: (2017)

Authors' reply [5]
由: Chen, Z, et al.
出版: (2006)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
由: Aayushee Rao, et al.
出版: (2023-07-01)

Authors' reply:
由: Garety, P, et al.
出版: (2008)

Fetal growth and ethnic variation--authors' reply.
由: Villar, J, et al.
出版: (2014)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.
由: Mónica Vázquez-Del Mercado, et al.
出版: (2018-01-01)

Author Reply
由: Krishna G Seshadri
出版: (2014-01-01)

Statins and diabetes - Authors' reply
由: Kearney, P, et al.
出版: (2008)

Author′s Reply
由: Farid E Stephan, et al.
出版: (2016-01-01)

Author's reply
由: Freeman, D
出版: (2008)

Safety and efficacy of statins - Authors' reply
由: Collins, R, et al.
出版: (2017)

Reply to author
由: Thao, L, et al.
出版: (2018)

Authors' Reply
由: Madhai L Teegala, et al.
出版: (2018-07-01)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
由: V. Erbasan, et al.
出版: (2023-03-01)

Authors′ reply
由: Vinita G Rao, et al.
出版: (2012-01-01)

Authors' reply.
由: Garety, P, et al.
出版: (2014)

Authors' Reply
由: P McKenna, et al.
出版: (2008-04-01)

Reply of the Authors
由: Jessica K. Wu, B.S, et al.
出版: (2022-12-01)

Authors′ Reply
由: Ramesh Kekunnaya, et al.
出版: (2014-01-01)

The Authors' reply.
由: Lasserson, D, et al.
出版: (2011)

The authors reply
由: David Vlahov, et al.

Author's Reply
由: Georgios D Panos, et al.
出版: (2018-01-01)

Authors' Reply
由: SV Vaidya, et al.
出版: (2004-06-01)

Authors' reply
由: Leucht, S, et al.
出版: (2013)